Cefepime 250mg, Tazobactam 31.25 Injection

Product Description: Cefepime 250mg + Tazobactam 31.25mg Injection is a Dry Powder Injection combining a fourth-generation cephalosporin (Cefepime) with a beta-lactamase inhibitor (Tazobactam). This combination enhances antibacterial activity and provides effective coverage against resistant bacterial strains. It is used in hospitals and clinics for the treatment of serious bacterial infections where other antibiotics may not be sufficient. The formulation is supplied in a sterile vial to ensure purity, safety, and stability. MRP: ?90Packing: VialType: Dry Powder Injection Indications: Cefepime + Tazobactam Injection is indicated for the treatment of: Lower respiratory tract infections (including pneumonia) Urinary tract infections (UTIs) Skin and soft tissue infections Intra-abdominal infections Gynecological infections Sepsis and bacteremia Complicated infections caused by resistant organisms Dosage & Administration: Adults: The usual recommended dose is equivalent to Cefepime 1–2g with Tazobactam 125–250mg every 12 hours, adjusted depending on the infection type and severity. Pediatric dosage: As directed by the physician, based on weight and infection severity. Route: Reconstitute the powder with sterile water for injection. Administer via intravenous (IV) or intramuscular (IM) route under medical supervision. Always follow your doctor’s directions for dosage and duration. Storage: Store below 25°C, protected from direct sunlight and moisture. Keep out of reach of children. Use immediately after reconstitution. Disclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Consult your healthcare provider before using Cefepime 250mg + Tazobactam 31.25mg Injection. The dosage and duration should be strictly followed as prescribed. Product specifications, pricing, and availability may vary as per regional guidelines.